Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(4S,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-N-(4-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-5,8,11,14-tetrakis((1H-indol-3-yl)methyl)-17,20,23,26,29-pentakis(3-guanidinopropyl)-3,6,9,12,15,18,21,24,27,30-decaoxo-1,4,7,10,13,16,19,22,25,28-decaazacyclotriacontan-2-yl)butyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxamide
ID: ALA5201645
Chembl Id: CHEMBL5201645
PubChem CID: 168292209
Max Phase: Preclinical
Molecular Formula: C97H135N33O14S
Molecular Weight: 2019.43
Associated Items: